Frank Striggow - Publications

1994-1996 Pharmacology Yale University, New Haven, CT 

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Haslbeck V, Drazic A, Eckl JM, Alte F, Helmuth M, Popowicz G, Schmidt W, Braun F, Weiwad M, Fischer G, Gemmecker G, Sattler M, Striggow F, Groll M, Richter K. Selective activators of protein phosphatase 5 target the autoinhibitory mechanism. Bioscience Reports. PMID 25892015 DOI: 10.1042/BSR20150042  0.64
2014 Kupsch A, Schmidt W, Gizatullina Z, Debska-Vielhaber G, Voges J, Striggow F, Panther P, Schwegler H, Heinze HJ, Vielhaber S, Gellerich FN. 6-Hydroxydopamine impairs mitochondrial function in the rat model of Parkinson's disease: respirometric, histological, and behavioral analyses. Journal of Neural Transmission (Vienna, Austria : 1996). 121: 1245-57. PMID 24627045 DOI: 10.1007/s00702-014-1185-3  0.64
2013 Trumbeckaite S, Gizatullina Z, Arandarcikaite O, Röhnert P, Vielhaber S, Malesevic M, Fischer G, Seppet E, Striggow F, Gellerich FN. Oxygen glucose deprivation causes mitochondrial dysfunction in cultivated rat hippocampal slices: protective effects of CsA, its immunosuppressive congener [D-Ser](8)CsA, the novel non-immunosuppressive cyclosporin derivative Cs9, and the NMDA receptor antagonist MK 801. Mitochondrion. 13: 539-47. PMID 22824458 DOI: 10.1016/j.mito.2012.07.110  0.64
2012 Seidel D, Krinke D, Jahnke HG, Hirche A, Kloß D, Mack TG, Striggow F, Robitzki A. Induced tauopathy in a novel 3D-culture model mediates neurodegenerative processes: a real-time study on biochips. Plos One. 7: e49150. PMID 23145103 DOI: 10.1371/journal.pone.0049150  0.64
2012 Schmidt W, Schäfer F, Striggow V, Fröhlich K, Striggow F. Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia. Neuroscience. 227: 313-26. PMID 23069763 DOI: 10.1016/j.neuroscience.2012.09.080  0.64
2012 Firsching R, Piek J, Skalej M, Rohde V, Schmidt U, Striggow F. Early survival of comatose patients after severe traumatic brain injury with the dual cannabinoid CB1/CB2 receptor agonist KN38-7271: a randomized, double-blind, placebo-controlled phase II trial. Journal of Neurological Surgery. Part a, Central European Neurosurgery. 73: 204-16. PMID 22696266 DOI: 10.1055/s-0032-1304815  0.64
2012 Röhnert P, Schmidt W, Emmerlich P, Goihl A, Wrenger S, Bank U, Nordhoff K, Täger M, Ansorge S, Reinhold D, Striggow F. Dipeptidyl peptidase IV, aminopeptidase N and DPIV/APN-like proteases in cerebral ischemia. Journal of Neuroinflammation. 9: 44. PMID 22373413 DOI: 10.1186/1742-2094-9-44  0.64
2012 Gellerich FN, Gizatullina Z, Trumbekaite S, Korzeniewski B, Gaynutdinov T, Seppet E, Vielhaber S, Heinze HJ, Striggow F. Cytosolic Ca2+ regulates the energization of isolated brain mitochondria by formation of pyruvate through the malate-aspartate shuttle. The Biochemical Journal. 443: 747-55. PMID 22295911 DOI: 10.1042/BJ20110765  0.64
2012 Jahnke HG, Braesigk A, Mack TG, Pönick S, Striggow F, Robitzki AA. Impedance spectroscopy based measurement system for quantitative and label-free real-time monitoring of tauopathy in hippocampal slice cultures. Biosensors & Bioelectronics. 32: 250-8. PMID 22221799 DOI: 10.1016/j.bios.2011.12.026  0.64
2012 Röhnert P, Schröder UH, Ziabreva I, Täger M, Reymann KG, Striggow F. Insufficient endogenous redox buffer capacity may underlie neuronal vulnerability to cerebral ischemia and reperfusion. Journal of Neuroscience Research. 90: 193-202. PMID 21971686 DOI: 10.1002/jnr.22754  0.64
2011 Gizatullina ZZ, Gaynutdinov TM, Svoboda H, Jerzembek D, Knabe A, Vielhaber S, Malesevic M, Heinze HJ, Fischer G, Striggow F, Gellerich FN. Effects of cyclosporine A and its immunosuppressive or non-immunosuppressive derivatives [D-Ser]8-CsA and Cs9 on mitochondria from different brain regions. Mitochondrion. 11: 421-9. PMID 21167961 DOI: 10.1016/j.mito.2010.12.012  0.64
2010 Krinke D, Jahnke HG, Mack TG, Hirche A, Striggow F, Robitzki AA. A novel organotypic tauopathy model on a new microcavity chip for bioelectronic label-free and real time monitoring. Biosensors & Bioelectronics. 26: 162-8. PMID 20591644 DOI: 10.1016/j.bios.2010.06.002  0.64
2010 Gellerich FN, Gizatullina Z, Trumbeckaite S, Nguyen HP, Pallas T, Arandarcikaite O, Vielhaber S, Seppet E, Striggow F. The regulation of OXPHOS by extramitochondrial calcium. Biochimica Et Biophysica Acta. 1797: 1018-27. PMID 20144582 DOI: 10.1016/j.bbabio.2010.02.005  0.64
2009 Gellerich FN, Gizatullina Z, Arandarcikaite O, Jerzembek D, Vielhaber S, Seppet E, Striggow F. Extramitochondrial Ca2+ in the nanomolar range regulates glutamate-dependent oxidative phosphorylation on demand. Plos One. 4: e8181. PMID 20011041 DOI: 10.1371/journal.pone.0008181  0.64
2009 Seppet E, Gruno M, Peetsalu A, Gizatullina Z, Nguyen HP, Vielhaber S, Wussling MH, Trumbeckaite S, Arandarcikaite O, Jerzembeck D, Sonnabend M, Jegorov K, Zierz S, Striggow F, Gellerich FN. Mitochondria and energetic depression in cell pathophysiology. International Journal of Molecular Sciences. 10: 2252-303. PMID 19564950 DOI: 10.3390/ijms10052252  0.64
2009 Jahnke HG, Rothermel A, Sternberger I, Mack TG, Kurz RG, Pänke O, Striggow F, Robitzki AA. An impedimetric microelectrode-based array sensor for label-free detection of tau hyperphosphorylation in human cells. Lab On a Chip. 9: 1422-8. PMID 19417909 DOI: 10.1039/b819754g  0.64
2008 Gellerich FN, Gizatullina Z, Nguyen HP, Trumbeckaite S, Vielhaber S, Seppet E, Zierz S, Landwehrmeyer B, Riess O, von Hörsten S, Striggow F. Impaired regulation of brain mitochondria by extramitochondrial Ca2+ in transgenic Huntington disease rats. The Journal of Biological Chemistry. 283: 30715-24. PMID 18606820 DOI: 10.1074/jbc.M709555200  0.64
2008 Hinners I, Hill A, Otto U, Michalsky A, Mack TG, Striggow F. Tau kinase inhibitors protect hippocampal synapses despite of insoluble tau accumulation. Molecular and Cellular Neurosciences. 37: 559-67. PMID 18201898 DOI: 10.1016/j.mcn.2007.12.004  0.64
2007 Seppet E, Gizatullina Z, Trumbeckaite S, Zierz S, Striggow F, Gellerich FN. Mitochondrial Medicine: The Central Role of Cellular Energetic Depression and Mitochondria in Cell Pathophysiology Molecular System Bioenergetics: Energy For Life. 479-520. DOI: 10.1002/9783527621095.ch15  0.64
2006 Edlich F, Weiwad M, Wildemann D, Jarczowski F, Kilka S, Moutty MC, Jahreis G, Lücke C, Schmidt W, Striggow F, Fischer G. The specific FKBP38 inhibitor N-(N',N'-dimethylcarboxamidomethyl)cycloheximide has potent neuroprotective and neurotrophic properties in brain ischemia. The Journal of Biological Chemistry. 281: 14961-70. PMID 16547004 DOI: 10.1074/jbc.M600452200  0.64
2006 Gizatullina ZZ, Lindenberg KS, Harjes P, Chen Y, Kosinski CM, Landwehrmeyer BG, Ludolph AC, Striggow F, Zierz S, Gellerich FN. Low stability of Huntington muscle mitochondria against Ca2+ in R6/2 mice. Annals of Neurology. 59: 407-11. PMID 16437579 DOI: 10.1002/ana.20754  0.64
2006 Henrich-Noack P, Striggow F, Reiser G, Reymann KG. Preconditioning with thrombin can be protective or worsen damage after endothelin-1-induced focal ischemia in rats. Journal of Neuroscience Research. 83: 469-75. PMID 16397902 DOI: 10.1002/jnr.20746  0.64
2006 Bukowska A, Lendeckel U, Hirte D, Wolke C, Striggow F, Röhnert P, Huth C, Klein HU, Goette A. Activation of the calcineurin signaling pathway induces atrial hypertrophy during atrial fibrillation. Cellular and Molecular Life Sciences : Cmls. 63: 333-42. PMID 16389460 DOI: 10.1007/s00018-005-5353-3  0.64
2004 Martínez-Sánchez M, Striggow F, Schröder UH, Kahlert S, Reymann KG, Reiser G. Na(+) and Ca(2+) homeostasis pathways, cell death and protection after oxygen-glucose-deprivation in organotypic hippocampal slice cultures. Neuroscience. 128: 729-40. PMID 15464281 DOI: 10.1016/j.neuroscience.2004.06.074  0.64
2004 Reiser G, Striggow F, Hackmann C, Schwegler H, Yilmazer-Hanke DM. Short-term down-regulation of the brain-specific, PtdIns(3,4,5)P3/Ins(1,3,4,5)P4-binding, adapter protein, p42IP4/centaurin-alpha 1 in rat brain after acoustic and electric stimulation. Neurochemistry International. 45: 89-93. PMID 15082226 DOI: 10.1016/j.neuint.2003.12.003  0.64
2002 Riek-Burchardt M, Striggow F, Henrich-Noack P, Reiser G, Reymann KG. Increase of prothrombin-mRNA after global cerebral ischemia in rats, with constant expression of protease nexin-1 and protease-activated receptors. Neuroscience Letters. 329: 181-4. PMID 12165407 DOI: 10.1016/S0304-3940(02)00645-6  0.64
2001 Striggow F, Riek-Burchardt M, Kiesel A, Schmidt W, Henrich-Noack P, Breder J, Krug M, Reymann KG, Reiser G. Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia. The European Journal of Neuroscience. 14: 595-608. PMID 11556885 DOI: 10.1046/j.0953-816X.2001.01676.x  0.64
2001 Schild L, Keilhoff G, Augustin W, Reiser G, Striggow F. Distinct Ca2+ thresholds determine cytochrome c release or permeability transition pore opening in brain mitochondria. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 15: 565-7. PMID 11259368 DOI: 10.1096/fj.00-0551fje  0.64
2000 Striggow F, Riek M, Breder J, Henrich-Noack P, Reymann KG, Reiser G. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proceedings of the National Academy of Sciences of the United States of America. 97: 2264-9. PMID 10681455 DOI: 10.1073/pnas.040552897  0.64
1997 Striggow F, Ehrlich BE. Regulation of intracellular calcium release channel function by arachidonic acid and leukotriene B4. Biochemical and Biophysical Research Communications. 237: 413-8. PMID 9268725 DOI: 10.1006/bbrc.1997.7152  0.64
1996 Striggow F, Ehrlich BE. The inositol 1,4,5-trisphosphate receptor of cerebellum. Mn2+ permeability and regulation by cytosolic Mn2+. The Journal of General Physiology. 108: 115-24. PMID 8854341  0.64
1996 Striggow F, Ehrlich BE. Ligand-gated calcium channels inside and out. Current Opinion in Cell Biology. 8: 490-5. PMID 8791458 DOI: 10.1016/S0955-0674(96)80025-1  0.64
1996 Fritz S, Striggow F, Reinhold D, Schlüter T, Schönfeld P, Ansorge S, Bohnensack R. Phorbol ester-induced shedding of intercellular adhesion molecule-1 (ICAM-1) on erythroleukemic K 562 cells. Biochimica Et Biophysica Acta. 1312: 255-61. PMID 8703996 DOI: 10.1016/0167-4889(96)00039-0  0.64
1994 Striggow F, Bohnensack R. Inositol 1,4,5-trisphosphate activates receptor-mediated calcium entry by two different pathways in hepatocytes. European Journal of Biochemistry / Febs. 222: 229-34. PMID 8200348 DOI: 10.1111/j.1432-1033.1994.tb18861.x  0.64
1993 Striggow F, Bohnensack R. Verapamil and diltiazem inhibit receptor-operated calcium channels and intracellular calcium oscillations in rat hepatocytes. Febs Letters. 318: 341-4. PMID 8382636 DOI: 10.1016/0014-5793(93)80542-3  0.64
1993 Kunz WS, Kuznetsov AV, Schulze W, Eichhorn K, Schild L, Striggow F, Bohnensack R, Neuhof S, Grasshoff H, Neumann HW, Gellerich FN. Functional characterization of mitochondrial oxidative phosphorylation in saponin-skinned human muscle fibers. Biochimica Et Biophysica Acta. 1144: 46-53. PMID 8347661 DOI: 10.1016/0005-2728(93)90029-F  0.64
Show low-probability matches.